Lonza | LONN - Selling And Administration Expenses

Stock Price
520.60
Daily Change
-15.80 -2.95%
Monthly
-5.69%
Yearly
-10.83%
Q1 Forecast
523.37

Lonza reported CHF20.7M in Selling and Administration Expenses for its fiscal semester ending in December of 2022.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 865M 5M Sep/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.2B 384M Sep/2025
Bayer EUR 3.4B 140M Sep/2025
Beiersdorf EUR 322M 1.68B Jun/2025
Covestro EUR 437M 12M Sep/2025
Demant DKK 6.09B 135M Dec/2025
Fresenius EUR 676M 64M Sep/2025
Fresenius Medical Care EUR 705.44M 86.56M Sep/2025
Geberit CHF 226M 38.6M Mar/2025
Genmab DKK 144M 18M Jun/2025
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GN Store Nord DKK 1.45B 41M Dec/2025
Hikma Pharmaceutical USD 139M 149M Jun/2025
Johnson Matthey GBP 170M 87M Dec/2025
Merck EUR 1.46B 16M Sep/2025
Novartis USD 3.31B 134M Sep/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Solvay EUR 115M 1000K Sep/2025
UCB EUR 1.29B 221M Dec/2024